FIELD: medicine, biochemistry.
SUBSTANCE: invention relates to a method for identifying epitopes of T-cells that induce the immune response in living organism-host. By this method immunogenicity-free biological compounds can be prepared or with reduced immunogenicity and in comparison with the corresponding unmodified object by decreasing or removing potential epitopes of T cells in limits of sequence of the parent immunogenic molecules. Also, invention relates to novel biological molecules being especially to proteins and antibodies prepared by the proposed invention. Invention provides reducing immunogenicity of biological compounds.
EFFECT: improved identifying method.
17 cl, 3 tbl, 8 dwg, 22 ex
Title | Year | Author | Number |
---|---|---|---|
MODIFIED ANTI-EGFR ANTIBODIES WITH REDUCED AMMONOGENICITY | 2002 |
|
RU2297245C2 |
MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS | 2013 |
|
RU2724994C2 |
ARTIFICIAL PROTEINS WITH LOWERED ADJUVANTICITY | 2002 |
|
RU2363707C2 |
METHOD OF T-CELL EPITOP CHARTERING AND ELIMINATION | 2003 |
|
RU2334235C2 |
ANTIBODIES AGAINST A5 REPRESENTATIVE OF 19 FAMILY WITH SIMILARITY OF SEQUENCES AND THEIR APPLICATION METHOD | 2019 |
|
RU2785436C2 |
PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES | 2014 |
|
RU2724370C2 |
METHODS OF PREDICTING THE APPLICABILITY OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY | 2018 |
|
RU2799341C2 |
COAGULATION FACTOR VIII WITH REDUCED IMMUNOGENICITY | 2013 |
|
RU2631801C2 |
RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
NEW IMMUNOGENIC PEPTIDES | 2015 |
|
RU2709711C2 |
Authors
Dates
2007-07-20—Published
2002-02-18—Filed